Home > Insider Trading > Filing (0000950170-24-097097)

Filing Details

Accession Number:: 0000950170-24-097097
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-14 16:34:26
Reporting Period:: 2024-08-12

Accepted Time:: 2024-08-14 16:34:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819790	Tarsus Pharmaceuticals Inc.	TARS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1228684	Phd J William Link	C/O Tarsus Pharmaceuticals, Inc. 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-08-12	74,892	$0.00	35,000	No	4	J	Indirect	By Flying L Partners XI, LLC
Common Stock	Acquisiton	2024-08-12	10,446	$0.00	10,446	No	4	J	Indirect	By Link Family Enterprise, LP
Common Stock	Acquisiton	2024-08-12	27,116	$0.00	167,098	No	4	J	Direct
Common Stock	Disposition	2024-08-12	29,979	$26.01	5,021	No	4	S	Indirect	By Flying L Partners XI, LLC
Common Stock	Disposition	2024-08-12	5,021	$26.53	0	No	4	S	Indirect	By Flying L Partners XI, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	By Flying L Partners XI, LLC
No	4	J	Indirect	By Link Family Enterprise, LP
No	4	J	Direct
No	4	S	Indirect	By Flying L Partners XI, LLC
No	4	S	Indirect	By Flying L Partners XI, LLC

Footnotes

Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Partners XI, LLC to its partners.
The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP.
The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $25.42 to $26.41. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.42 to $26.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.